Medicinal product rebate agreements from 01/06/2026 for various active substances under an open-house procedure

Summary

The tender concerns the conclusion of rebate agreements for various medicinal active substances starting on 01/06/2026. It is an open-house procedure, meaning that all suitable and interested pharmaceutical companies are offered the contract on the same terms and through the same access procedure. The contract term is up to 24 months. The bidder must be a pharmaceutical undertaking and that status must remain valid for the whole contract period.